Saga Lifesciences Limited Revenue and Competitors

Saga Lifesciences is a four-decade-old pharmaceutical company, growing at a rate of 30% YOY since its inception, with exports to over 40 countries spanning Europe, Asia, CIS, Latin America, Africa, and Canada. Manufacturing Facility: We have an ultramodern manufacturing facility with large capacities. The facility is PIC/s, EU GMP (European Union), TGA Australia GMP, Health Canada, and WHO GMP certified. It complies with all international GMP norms and approved by several international regulators and auditors, including the countries where we have a commercial presence. Product Range: We manufacture a wide range of solid oral dosage forms like tablets, capsules, dry syrups, and oral powders that include general & cephalosporins. It also supplies products in liquids, injections, and ointments dosage forms. Saga can deliver a wide range of formulations in diverse dosage forms to serve the needs of healthcare professionals and patients for its customers. Development: We have an in-house formulation and development wing competent to develop the latest formulations bio-equivalent to innovators. We work on a wide range of novel delivery systems such as instant release tablets, bi-layered tablets, mouth dispersible tablets, chewable tablets, enteric-coated tablets, and sustained or delayed-release tablets and tablets, and capsules with different or specialized release patterns. Regulatory Support: We have a full-fledged regulatory affairs division to register dossier and technical information. We have developed a stability profile for each product which we manufacture to ensure that the products meet predefined standards throughout its shelf life and are stable throughout all the kinds of climatic conditions where it is intended to be exported. We can provide registration dossiers in CTD, ACTD format, or country-specific formats and provide all the documents required for registration of the product.